Warning letterFDA · Jan 11, 2018
Named company: Soothedrawal, Inc.
In addition, the Federal Trade Commission has reviewed your marketing claims for your “Soothedrawal Daytime Formula” and “Soothedrawal Nighttime Formula” products for potential violations of Sections 5 and 12…
Warning letterFDA · Jan 11, 2018
Named company: TaperAid
In addition, the Federal Trade Commission has reviewed your marketing claims for your “TaperAid” products for potential violations of Sections 5 and 12 of the FTC Act, 15 U.S.C. §§ 45(a) and 52. A drug is…
Warning letterFDA · Jan 11, 2018
Named company: U4Life LLC dba Mitadone
In addition, the Federal Trade Commission has reviewed your marketing claims for “Mitadone Anti-Opiate Aid Plus Extra Strength” for potential violations of Sections 5 and 12 of the FTC Act, 15 U.S.C §§ 45(a)…
Warning letterFDA · Jan 11, 2018
Named company: Guna Inc.
Your product is an unapproved new drug under section 505(a) of the Federal Food, Drug, and Cosmetic Act (the Act), 21 U.S.C. 355(a), and a misbranded drug under sections 503(b) and 502(f)(1) of the Act, 21…
Warning letterFDA · Jan 11, 2018
Named company: CalmSupport.com, LLC
In addition, the Federal Trade Commission has reviewed your marketing claims for “CalmSupport” for potential violations of Sections 5 and 12 of the FTC Act, 15 U.S.C. §§ 45(a) and 52. This YouTube page links…
Warning letterFDA · Jan 11, 2018
Named company: King Bio Inc.
Your product is an unapproved new drug under section 505(a) of the Federal Food, Drug, and Cosmetic Act (the Act), 21 U.S.C. 355(a), and a misbranded drug under sections 503(b) and 502(f)(1) of the Act, 21…
Warning letterFDA · Jan 11, 2018
Named company: Opiate Freedom Center
In addition, the Federal Trade Commission has reviewed your marketing claims for "Opiate Freedom 5-Pack" for potential violations of Sections 5 and 12 of the FTC Act, 15 U.S.C §§ 45(a) and 52. A drug is…
Warning letterFDA · Jan 11, 2018
Named company: NutraCore Health Products
In addition, the Federal Trade Commission has reviewed your marketing claims for “Opiate Detox Pro” for potential violations of Sections 5 and 12 of the FTC Act, 15 U.S.C. §§ 45(a) and 52. A drug is misbranded…
Warning letterFDA · Jan 11, 2018
Named company: Medicus Holistic Alternatives LLC
In addition, the Federal Trade Commission has reviewed your marketing claims for “Natracet” for potential violations of Sections 5 and 12 of the FTC Act, 15 U.S.C §§ 45(a) and 52. A drug is misbranded under…
Warning letterFDA · Jan 11, 2018
Named company: Choice Detox Center, Inc. dba Nofeel
In addition, the Federal Trade Commission has reviewed your marketing claims for “Nofeel” for potential violations of Sections 5 and 12 of the FTC Act, 15 U.S.C. §§ 45(a) and 52. A drug is misbranded under…